A pooled data analysis of 17 studies demonstrated that women with higher circulating IGF-1 levels have a higher risk of breast cancer, and that this is especially true for ER+ (estrogen receptor-positive) breast cancer development [14]. This evidence concerns the gene IGF1 and breast cancer.